Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 JHP Pharmaceuticals Enters Manufacturing Pact | Contract Pharma
Breaking News

JHP Pharmaceuticals Enters Manufacturing Pact

JHP Pharmaceuticals has entered into a multi‐year contract manufacturing agreement with an undisclosed biotechnology company.

JHP Pharmaceuticals has entered into a multi‐year contract manufacturing agreement with an undisclosed biotechnology company. JHP will be responsible for the manufacture and supply of an approved therapy used to treat cancer.

Stuart Hinchen, president and co‐founder of JHP, said, “We recognize that being selected to produce this crucial drug demonstrates our ability to meet critical marketplace needs. JHP was able to achieve the rigorous timelines required to manufacture this drug through a quality‐driven, experienced staff and a customer‐centric approach. Additionally, our record of cGMP compliance, coupled with our experience in manufacturing site transfers, put us in the position to serve this important customer.”

Mr. Hinchen also noted, “This will be the second multi‐year contract JHP has entered during the last two months. These agreements are examples of how our approach to ongoing investment in our people and facilities allow us to focus on customer needs which results in rising, sustainable growth. Our Rochester, MI manufacturing site has a solid history of successful partnerships, manufacturing both clinical and commercial products.”


Click here to learn more about JHP Pharmaceuticals

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters